| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 03/04/2009 | EP2029581A1 P38 inhibitors and methods of use thereof |
| 03/04/2009 | EP2029580A1 Novel indol-pyrrol derivatives for the treatment of proliferative and inflammatory diseases |
| 03/04/2009 | EP2029579A2 Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 03/04/2009 | EP2029578A1 2-carbocycloamino-4-imidaz0lylpyrimidines as agents for the inhbition of cell proliferation |
| 03/04/2009 | EP2029576A1 Cyclohexylimidazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 03/04/2009 | EP2029558A2 Compounds and methods for modulating fxr |
| 03/04/2009 | EP2029553A1 Substituted pyrazinone derivatives for use as a medicine |
| 03/04/2009 | EP2029551A2 Pyridinone and pyridazinone derivatives as inhibitors of poly(adp-ribose)polymerase (parp) |
| 03/04/2009 | EP2029550A2 1-sulfonylindazolylamine and -amide derivatives as 5-hydroxytryptamine-6 ligands |
| 03/04/2009 | EP2029547A1 Fxr agonists |
| 03/04/2009 | EP2029530A1 Ethenyl carboxamide derivatives useful as microbiocides |
| 03/04/2009 | EP1899328B1 A process for the preparation of losartan derivatives by chlorination and reduction of the respective 1h-imidazole-5-carbaldehydes |
| 03/04/2009 | EP1706376B1 Imidazole derivatives, processes for preparing them and their uses |
| 03/04/2009 | EP1660443B1 Cyclic amine bace-1 inhibitors having a benzamide substituent |
| 03/04/2009 | EP1551812B1 Mitotic kinesin inhibitors |
| 03/04/2009 | EP1485370B1 Amino-derivatives as novel inhibitors of histone deacetylase |
| 03/04/2009 | EP1452527B1 Azabicyclo compound, matrix metalloprotease inhibitor, and skin preparation |
| 03/04/2009 | EP1140908B1 Triazole compounds with dopamine-d3-receptor affinity |
| 03/04/2009 | CN101379060A Benzazole derivatives, compositions, and methods of use as Aurora kinase inhibitors |
| 03/04/2009 | CN101379059A N-hydroxyacrylamide compounds |
| 03/04/2009 | CN101379058A Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinases |
| 03/04/2009 | CN101379042A Substituted cinnoline derivatives as GABAA-receptor modulators and method for their synthesis |
| 03/04/2009 | CN101379030A Sulfonamide derivatives to treat infection with hepatitis c virus |
| 03/04/2009 | CN101379028A Chemical compounds |
| 03/04/2009 | CN100465173C A selective kinase inhibitor |
| 03/04/2009 | CN100465163C Cis-2,4,5-triaryl-imidazolines |
| 03/03/2009 | US7498439 Synthesis of heteroaryl acetamides from reaction mixtures having reduced water content |
| 03/03/2009 | US7498435 One amine is substituted with a fused heterocyclic ring and the other with a fused heterocyclic ring or phenyl ring, e.g., N2,N4-Bis(3,4-ethylenedioxyphenyl)-5-cyano-2,4-pyrimidinediamine; inhibit IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators such as histamine |
| 03/03/2009 | US7498335 Method of producing an antiangiogenic or vascular permeability reducing effect |
| 03/03/2009 | US7498328 Derivatives of sulphonamides, their preparation and use as medicaments |
| 03/03/2009 | CA2258165C N-[4-(heteroarylmethyl)phenyl]-heteroarylamines |
| 02/26/2009 | WO2009026326A1 Naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system |
| 02/26/2009 | WO2009026319A1 Naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system |
| 02/26/2009 | WO2009026276A1 5- (4- (haloalkoxy) phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors |
| 02/26/2009 | WO2009025823A1 Phosphodiesterase 10 inhibitors |
| 02/26/2009 | WO2009025265A1 Piperazine derivative |
| 02/26/2009 | WO2009024906A1 4-pyrimidinesulfamide derivative |
| 02/26/2009 | WO2009024825A1 2-pyrazinylbenzimidazole derivatives as receptor tyrosine kinase inhibitors |
| 02/26/2009 | WO2009024502A1 Pyrrolidine aryl-ether as nk3 receptor antagonists |
| 02/26/2009 | WO2009024342A2 Novel microbiocides |
| 02/26/2009 | WO2009024221A1 6-thioxo-pyridazine derivatives |
| 02/26/2009 | WO2009024214A1 Process for the production of voriconazole |
| 02/26/2009 | WO2009003998A3 Antiproliferative compounds based on 5-membered heterocycles |
| 02/26/2009 | WO2008140553A3 Mapk/erk kinase inhibitors |
| 02/26/2009 | WO2008005368A3 Piperazines as p2x7 antagonists |
| 02/26/2009 | WO2007014226A3 Compounds for the treatment of neurodegeneration and stroke |
| 02/26/2009 | US20090054645 Bridge compound with N, N-dialkylamino group and application thereof |
| 02/26/2009 | US20090054644 Pyrrolidine aryl-ether as nk3 receptor antagonists |
| 02/26/2009 | US20090054509 Octahydropentalene-Substituted Pyrazoline Derivatives, Their Prepartion and Use as Medicaments |
| 02/26/2009 | US20090054466 Leukotriene B4 Inhibitors |
| 02/26/2009 | US20090054465 N-hydroxyacrylamide compounds |
| 02/26/2009 | US20090054462 Hydroisoindoline tachykinin receptor antagonists |
| 02/26/2009 | US20090054460 Piperazine derivatives and methods of use |
| 02/26/2009 | US20090054459 Substituted indoles |
| 02/26/2009 | US20090054453 Novel Tetralins as 5-HT6 Modulators |
| 02/26/2009 | US20090054450 Compositions and methods of use for treating or preventing lipid related disorders |
| 02/26/2009 | US20090054449 Substituted N-heterocyclic Compounds and Their Use as Dopamine D3 Receptor Ligands |
| 02/26/2009 | US20090054448 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors |
| 02/26/2009 | US20090054447 2,3 Substituted Pyrazine Sulfonamides as Inhibitors of CRTH2 |
| 02/26/2009 | US20090054445 Amide Substituted Quinolines |
| 02/26/2009 | US20090054432 2-(2-Hydroxybiphenyl-3-yl)-1H-Benzoimidazole-5-Carboxamidine Derivatives as Factor VIIA Inhibitors |
| 02/26/2009 | US20090054429 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods |
| 02/26/2009 | US20090054423 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 02/26/2009 | US20090054420 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 02/26/2009 | US20090054409 [4-(4-imidazo[1,2-a]pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-morpholin-4-yl-methanone, used for treating rheumatoid arthritis in mammals |
| 02/26/2009 | US20090054407 such as 4-Methanesulfonyloxy-5-methoxy-7-[1H-5-(methylaminomethyl)indol-2-yl]isoindolinone, having an antitumor activity |
| 02/26/2009 | US20090054402 7-substituted indole mcl-1 inhibitors |
| 02/26/2009 | US20090054397 Pyrazole compounds and pharmaceutical compositions comprising the compound |
| 02/26/2009 | US20090054395 focal adhesion kinase inhibitor, i.e. FAK inhibitor; tyrosine kinase inhibitors; cancer, osteoporosis; e.g. N-methyl-4-({4-[({3-[methyl(methylsulfonyl)amino]pyrazin-2-yl}methyl)amino]-5-(trifluoromethyl)pyrimidin-2-yl}amino)benzamide hydrochloride |
| 02/26/2009 | US20090054392 Naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system |
| 02/26/2009 | CA2697325A1 Pyrrolidine aryl-ether as nk3 receptor antagonists |
| 02/26/2009 | CA2697100A1 Naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system |
| 02/26/2009 | CA2697081A1 5-(4-(haloalkoxy)phenyl)pyrimidine-2-amine compounds and compositions as kinase inhibitors |
| 02/26/2009 | CA2696472A1 6-thioxopyridazine derivatives |
| 02/26/2009 | CA2695511A1 4-pyrimidinesulfamide derivative |
| 02/25/2009 | EP2027120A2 Mglur5 modulators i |
| 02/25/2009 | EP2027119A2 Ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 02/25/2009 | EP2027114A1 Maleate co-crystal of azd1152 |
| 02/25/2009 | EP2027113A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 02/25/2009 | EP2027110A2 Mglur5 modulators iii |
| 02/25/2009 | EP2027096A1 Substituted arylimidaz0l0ne and triaz0l0ne as inhibitors of vasopressin receptors |
| 02/25/2009 | EP2027088A2 Compounds for the treatment of spinal muscular atrophy and other uses |
| 02/25/2009 | EP1885695B1 Indoline compounds |
| 02/25/2009 | EP1027056B1 Alpha-ketoamide multicatalytic protease inhibitors |
| 02/25/2009 | CN101374830A Alpha2C adrenoreceptor agonists |
| 02/25/2009 | CN101374829A Inhibitors of IAP |
| 02/25/2009 | CN101374820A Piperazine compounds with a herbicidal action |
| 02/25/2009 | CN101374818A Pyrimidine derivatives |
| 02/25/2009 | CN101374817A Trisubstituted amine compound as inhibitors of cholesteryl ester transfer protein cetp |
| 02/25/2009 | CN101374808A Indole sulfonamide modulators of progesterone receptors |
| 02/25/2009 | CN101374804A Substituted diphenylethers, -amines, -sulfides and -methanes for the treatment of respiratory disease |
| 02/25/2009 | CN101372474A 2-(1h-indolylsulfanyl)-benzyl amine derivatives as SSRI |
| 02/24/2009 | US7495110 Benzimidazole derivatives and their use as GnRH antagonists |
| 02/24/2009 | US7495109 Nociceptin analogs |
| 02/24/2009 | US7495016 inhibiting HIV replication in a cell; inhibiting reverse transcriptase |
| 02/24/2009 | US7495014 Gyrase inhibitors and uses thereof |
| 02/24/2009 | US7495012 Arylsulfonamides and uses related thereto |
| 02/24/2009 | US7494997 excellent BCR-ABL tyrosine kinase inhibitory activity; to treat leukemias; 3-bromo-4-(4-methylpiperazin-1-ylmethyl)-N-{4-methyl-3-[4-(3-pyridyl)pyrimidin-2-ylamino]phenyl}benzamide; compounds with cell growth inhibitory effect |
| 02/24/2009 | US7494989 Pyridine compounds useful as N-type calcium channel antagonists |
| 02/24/2009 | CA2469813C Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5 |